Does immunohistochemistry affect response to therapy and survival of inoperable non-small cell lung carcinoma patients? A survey of 145 stage III-IV consecutive cases.

Does immunohistochemistry affect response to therapy and survival of inoperable non-small cell lung carcinoma patients? A survey of 145 stage III-IV consecutive cases. Int J Surg Pathol. 2014 Apr; 22(2):136-48.

View in: PubMed

subject areas

Adult
Aged
Aged, 80 and over
Carcinoma, Non-Small-Cell Lung
Female
Humans
Immunohistochemistry
Lung Neoplasms
Male
Middle Aged
Neoplasm Staging
Prognosis
Survival Rate
Treatment Outcome

authors with profiles

Marina Chiara Garassino